FDA issues H1N1 warning letters
This article was originally published in The Tan Sheet
Executive Summary
FDA warns Cashburners, the website manager and host site for Flu Defence dietary supplement - sold on fludefence.org, fludefence.net and swinefludefence.org - to stop marketing the supplement, because it is unapproved by FDA to diagnose, mitigate, prevent, treat or cure H1N1. In warning letters sent June 2 to the domain protector and website marketer located in New Zealand, the Netherlands and Westchester, Calif., the agency takes issue with claims including "[E]xhibits strong antiviral action against influenza A & 8, birdflu ... swine flu." FDA teamed with the Federal Trade Commission and foreign governments to root out improper claims regarding products that treat or prevent H1N1 flu (1"The Tan Sheet" Oct. 19, 2009). FDA also warned Nature's Gift in a letter posted June 11 to discontinue claims on its blog that Flu Foil Synergy, Flu Foil Synergy with Inhaler, Ravensara and Ravintsara could diagnose, mitigate, prevent, treat or cure H1N1 because the products are unapproved